News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
286,240 Results
Type
Article (15038)
Company Profile (302)
Press Release (270894)
Multimedia
Podcasts (78)
Webinars (11)
Section
Business (80818)
Career Advice (177)
Deals (13512)
Drug Delivery (39)
Drug Development (51229)
Employer Resources (31)
FDA (5957)
Job Trends (5298)
News (147039)
Policy (10393)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (936)
Academic (1)
Accelerated approval (19)
Adcomms (14)
Allergies (81)
Alliances (22069)
ALS (125)
Alzheimer's disease (1036)
Antibody-drug conjugate (ADC) (248)
Approvals (6163)
Artificial intelligence (260)
Autoimmune disease (116)
Automation (9)
Bankruptcy (106)
Best Places to Work (4686)
BIOSECURE Act (6)
Biosimilars (102)
Biotechnology (230)
Bladder cancer (104)
Brain cancer (46)
Breast cancer (365)
Cancer (3216)
Cardiovascular disease (240)
Career advice (159)
Career pathing (7)
CAR-T (222)
CDC (5)
Cell therapy (570)
Cervical cancer (14)
Clinical research (44163)
Collaboration (1164)
Company closure (2)
Compensation (596)
Complete response letters (39)
COVID-19 (1111)
CRISPR (86)
C-suite (557)
Cystic fibrosis (112)
Data (4391)
Denatured (15)
Depression (92)
Diabetes (263)
Diagnostics (1456)
Digital health (10)
Diversity (5)
Diversity, equity & inclusion (9)
Drug discovery (190)
Drug pricing (49)
Drug shortages (3)
Duchenne muscular dystrophy (216)
Earnings (32071)
Editorial (25)
Employer branding (4)
Employer resources (29)
Events (52438)
Executive appointments (625)
FDA (7737)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (9)
Frontotemporal dementia (22)
Funding (983)
Gene editing (182)
Generative AI (21)
Gene therapy (491)
GLP-1 (517)
Government (1256)
Grass and pollen (3)
Guidances (172)
Healthcare (6757)
HIV (19)
Huntington's disease (43)
IgA nephropathy (74)
Immunology and inflammation (193)
Immuno-oncology (40)
Indications (68)
Infectious disease (1216)
Inflammatory bowel disease (157)
Inflation Reduction Act (10)
Influenza (38)
Intellectual property (168)
Interviews (20)
IPO (7430)
IRA (12)
Job creations (875)
Job search strategy (141)
JPM (40)
Kidney cancer (9)
Labor market (22)
Layoffs (245)
Leadership (9)
Legal (1437)
Liver cancer (42)
Longevity (11)
Lung cancer (445)
Lymphoma (252)
Machine learning (24)
Management (7)
Manufacturing (383)
MASH (131)
Medical device (2760)
Medtech (2769)
Mergers & acquisitions (6709)
Metabolic disorders (737)
Multiple sclerosis (104)
NASH (13)
Neurodegenerative disease (233)
Neuropsychiatric disorders (70)
Neuroscience (1961)
Neurotech (1)
NextGen: Class of 2026 (2068)
Non-profit (888)
Now hiring (32)
Obesity (333)
Opinion (125)
Ovarian cancer (131)
Pain (102)
Pancreatic cancer (162)
Parkinson's disease (234)
Partnered (12)
Patents (302)
Patient recruitment (331)
Peanut (43)
People (26886)
Pharmaceutical (44)
Pharmacy benefit managers (6)
Phase 1 (15594)
Phase 2 (20485)
Phase 3 (13035)
Pipeline (3304)
Policy (91)
Postmarket research (866)
Preclinical (6568)
Press Release (33)
Prostate cancer (149)
Psychedelics (50)
Radiopharmaceuticals (239)
Rare diseases (655)
Real estate (1496)
Recruiting (12)
Regulatory (10115)
Reports (19)
Research institute (983)
Resumes & cover letters (21)
Rett syndrome (24)
RNA editing (21)
RSV (16)
Schizophrenia (123)
Series A (183)
Series B (136)
Service/supplier (2)
Sickle cell disease (77)
Special edition (18)
Spinal muscular atrophy (119)
Sponsored (15)
Startups (2022)
State (1)
Stomach cancer (5)
Supply chain (33)
Tariffs (18)
The Weekly (62)
Vaccines (340)
Venture capital (69)
Weight loss (174)
Women's health (25)
Worklife (2)
Date
Today (47)
Last 7 days (326)
Last 30 days (1185)
Last 365 days (18088)
2026 (1726)
2025 (18333)
2024 (20847)
2023 (22740)
2022 (27281)
2021 (28236)
2020 (23803)
2019 (16605)
2018 (12023)
2017 (13912)
2016 (12028)
2015 (14532)
2014 (10538)
2013 (7637)
2012 (7687)
2011 (7770)
2010 (7529)
Location
Africa (165)
Alabama (65)
Alaska (2)
Arizona (71)
Arkansas (5)
Asia (18778)
Australia (3143)
California (7149)
Canada (1862)
China (802)
Colorado (247)
Connecticut (262)
Delaware (241)
Europe (39841)
Florida (910)
Georgia (209)
Hawaii (2)
Idaho (17)
Illinois (413)
India (35)
Indiana (162)
Iowa (8)
Japan (227)
Kansas (82)
Kentucky (10)
Louisiana (7)
Maine (11)
Maryland (741)
Massachusetts (5625)
Michigan (110)
Minnesota (259)
Mississippi (3)
Missouri (32)
Montana (16)
Nebraska (5)
Nevada (33)
New Hampshire (21)
New Jersey (1700)
New Mexico (13)
New York (1769)
North Carolina (831)
North Dakota (6)
Northern California (3513)
Ohio (177)
Oklahoma (11)
Oregon (24)
Pennsylvania (1325)
Puerto Rico (9)
Rhode Island (25)
South America (221)
South Carolina (9)
Southern California (2835)
Tennessee (40)
Texas (913)
United States (23630)
Utah (97)
Virginia (137)
Washington D.C. (37)
Washington State (598)
West Virginia (1)
Wisconsin (45)
286,240 Results for "GC therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
GC Therapeutics Appoints Kate Haviland as Board Chair and Provides Corporate Update
January 9, 2026
·
6 min read
Press Releases
GC Biopharma Secures IND Approval for Phase 1 Clinical Trial of COVID-19 mRNA Vaccine in Korea
December 23, 2025
·
3 min read
Press Releases
GC Biopharma’s Varicella Vaccine Strain ‘MAV/06' Listed in WHO Position Paper
December 2, 2025
·
3 min read
Press Releases
GC Biopharma Ships First Doses of World’s First Recombinant Anthrax Vaccine, ‘BARYTHRAX inj.’
December 8, 2025
·
3 min read
Press Releases
GC Genome Publishes Blood-Based Colorectal Cancer Screening Study in the American Journal of Gastroenterology
November 27, 2025
·
2 min read
Press Releases
GC Biopharma Secures CMO Rights for Shingles Vaccine from Curevo Vaccine
October 13, 2025
·
3 min read
Press Releases
Immunofoco Presents Phase I/IIa Data of IMC002 at ASCO GI 2026, Highlighting a Durable Complete Response Beyond One Year and a 66.7% ORR in Advanced GC/GEJ
January 13, 2026
·
5 min read
Press Releases
GC Biopharma’s Recombinant Anthrax Vaccine, BARYTHRAX, Demonstrates Safety and Immunogenicity in Phase 2 Data, Published in ‘Vaccine’
November 3, 2025
·
4 min read
Press Releases
GC Biopharma Supports New Insights into Education, Safety, and Patient Outcomes in Ig Therapy Care at the 2025 IgNS Annual Meeting
November 7, 2025
·
7 min read
Press Releases
GC Biopharma Highlights IVIG Innovation and Investigator-Initiated Research as Science to Solutions Partner at the Fall 2025 CIIC Conference
October 14, 2025
·
7 min read
1 of 28,624
Next
